|
項目 |
合約生效日 |
合約到期日 |
授權技術名稱 |
|
1 |
2017/01/01 |
2032/01/06 |
02A-980520 Fabricating scaffolds by microfluidics |
|
02A-1010123 Fabricating porous martials by the bubble-mixing microfluidic device. |
|||
|
2 |
2020/12/28 |
2037/01/19 |
05A-1041113 Building/environment data-based indoor positioning System (BeDIPS) |
|
3 |
2019/12/01 |
2039/11/30 |
07A-1040804 Supercontinuum Generating Device and Method |
|
4 |
2021/01/28 |
2038/08/06 |
07A-1060323 High content cell image-registered photo-induced labeling system |
|
07A-1091118 A device to illuminate microscopic patterns in a large area |
|||
|
07T-1100625 光標靶儀技術介紹動畫 |
|||
|
07T-1100626 Software, firmware, IC layout design, and industrial design of the optoproteomics system |
|||
|
5 |
2019/03/21 |
2037/01/06 |
08A-980430 A novel method to constuct two-fluid molten salt reactors |
|
08A-990330 supertorrefaction with liquids as heat transfer agent |
|||
|
08A-1030401 Supertorrefaction by Batch Process |
|||
|
6 |
2013/02/01 |
2035/04/30 |
10A-1001025 Anti-EpCAM monoclonal antibodies 3-5-2 |
|
7 |
2020/09/14 |
2042/06/23 |
10A-1001025 Anti-EpCAM monoclonal antibodies 3-5-2 |
|
10A-1081029 EpCAM/EpEX signaling promotes PD-L1 stability through EGFR-ERK signaling in lung cancer cells |
|||
|
10A-1091104 Signaling of EpCAM, HFGR and beta-catenin |
|||
|
8 |
2015/05/01 |
2035/04/30 |
10A-1001025B anti_EpCAM antibody OCAb9-1、EpAb1-3、EpAb5-4 |
|
9 |
2018/12/01 |
2034/12/28 |
10A-1030805 Pardaxin treatment of perianal gland adenoma in dog. |
|
10 |
2019/08/01 |
2037/07/31 |
10A-990101 targeting peptide |
|
11 |
2017/07/14 |
2037/07/14 |
10A-990625 Application of monoclonal antibodies against dengue virus type 2 in diagnosis and therap |
|
12 |
2018/10/01 |
2038/10/01 |
10T-1070223 Thrombus-targeted peptides |
|
13 |
2021/01/21 |
2041/01/20 |
10T-1090709Development of human antibody mice |
|
14 |
2021/01/08 |
2041/01/07 |
10T-1090714 Development of Anti-M13 Antibodies |
|
15 |
2021/01/05 |
2041/01/04 |
10T-1090715 Development of anti-HER3 therapeutic antibodies |
|
16 |
2018/05/23 |
2033/07/15 |
11A-1010209 Specific A1AT Monoclonal Antibodies For Detection of Endometriosis |
|
17 |
2016/09/26 |
2034/09/14 |
11A-1030801 HDAC8 inhibitors for treating cancer |
|
18 |
2020/05/01 |
2037/10/02 |
11A-1060407 Klebsielle pneumoniae capsule polysaccharide conjugated vaccines |
|
19 |
2014/05/30 |
2035/05/20 |
11A-941227 Monocotyledon plant indications extract compositions, method of preparation and pharmaceutical compositions containing them |
|
11A-1020917 Biological application of Trans-Aconitic Acid (TAA) as a Phosphodiesterase 7 inhibitor |
|||
|
11A-970326 Cardioprotection by water extracts from monocotyledon plant |
|||
|
20 |
2009/05/11 |
2029/04/23 |
11A-971229 Protein Expression System Involving Mutated Severe Respiratory Syndrome-Associated Coronavirus 3C-Like Protease |
|
21 |
2016/01/01 |
2035/12/31 |
12A-1030310 A reloadable delivery system for systemically administered therapeutics |
|
22 |
2014/12/07 |
2036/08/31 |
28A-1031012 Small molecules for breast cancer therapy |
|
12A-1030616 An antagonistic CTLA-4 aptamer and its applications in cancer therapy |
|||
|
12A-1030619 An antagonistic PD1 aptamer and its applications in cancer therapy |
|||
|
12A-1021016 Dnazyme for silencing the expression of EGFR |
|||
|
12A-1040126 An antagonistic PDL1 aptamer and its applications in cancer therapy. |
|||
|
28A-1030629 Small molecules for lung cancer therapy |
|||
|
12T-1031121 An all-round platfrom technology for rapid aptamer identification |
|||
|
23 |
2016/12/16 |
2036/12/15 |
12A-1050113 Concurrent direct human leukocyte antigen (HLA) genotyping and genome-wide association study (GWAS) reveal major genetic determinants of anti-thyroid druginduced agranulocytosis |
|
24 |
2020/08/01 |
2037/07/27 |
12A-1050421 Internal fixation of cells and organisms and uses thereof |
|
25 |
2005/11/01 |
2025/10/31 |
12A-920716 Risk assessment for adverse drug reactions |
|
12A-931129 Genetic variants predicting warfarin sensitivity |
|||
|
26 |
2009/09/15 |
2026/09/07 |
13A-930703 Subcutaneous G-CSF injection in combination with autologous mobilized peripheral blood-hematopoietic stem cell (CD34+) transplantation in chronic stroke animal model |
|
27 |
2018/05/15 |
2028/07/31 |
13A-930909 Functional and anatomical recovery in stroke rats receiving intracerebral transplantation of human umbilical cord-derived mesenchymal stem cells |
|
28 |
2014/05/10 |
2034/05/09 |
14A-1020222 Use of plant extracts as preventive or therapeutic intervention for fulminant hepatitis, sepsis and sepsis-induced kidney injury, and as de-pigmentation agent |
|
29 |
2021/09/08 |
2040/11/14 |
14A-1030111 Pdia4 for diabetes diagnosis and treatment |
|
14A-1080729 Pdia4 inhibitors for beta-cell function and diabetes treatment |
|||
|
30 |
2008/10/01 |
2028/09/30 |
14A-940824 Use of Wedelolactone and IKKα inhibitors to control prostate cancer, benign prostate hypertrophy and androgen-regulated diseases |
|
31 |
2018/11/12 |
2028/11/11 |
14A-941103 Use of 2 β-D-glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-triyne (cytopiloyne) to treat type 2 diabetes |
|
32 |
2014/06/01 |
2114/05/31 |
14A-950305 Use of active galactolipid fraction or derived pure compounds from the Crassocephalum rabens extract as cancer chemopreventive agents |
|
33 |
2019/10/08 |
2039/10/07 |
16T-950724 Voices of Orchid Island |
|
34 |
2018/06/26 |
2028/06/25 |
19T-1070521 The Souls of Black Folk |
|
35 |
2020/12/01 |
2025/11/30 |
19T-1090616 The EU Banking Union: Theories and Policies |
|
36 |
2022/01/01 |
2026/12/31 |
19T-1100726 Civil Philosophy |
|
37 |
2012/07/10 |
2028/06/27 |
21T-960330 荒木見悟著「佛教與儒教」 |
|
38 |
2013/09/17 |
2028/09/16 |
21T-970430 Prolegomena to Any Future Metaphysics |
|
39 |
2022/03/09 |
2041/11/13 |
26A-1080709 Helix Air Bladder Based High Efficiency ECP System |
|
40 |
2013/04/11 |
2036/01/27 |
28A-1000423 Surface modification to promote binding specific circulating tumor cell detection (Method of Surface Coating to Capture, Purify, and Release Rare Cells |
|
28A-1010606 Two-Module Microfluidic System for Rare Cell Capturing and Analysis |
|||
|
28A-1030401 Methods and systems for cancer diagnosis and prognosis |
|||
|
28A-1040320 COLLECTOR ARCHITECTURE LAYOUT DESIGN |
|||
|
41 |
2014/04/23 |
2033/08/26 |
28A-1010820 寡醣之大規模酵素合成/Large Scale Enzymatic Synthesis of Oligosaccharides |
|
42 |
2014/11/10 |
2114/11/10 |
28A-1030530 Humanized anti-IgE antibodies that crosslink CD23 on B lymphocytes but do not sensitize cells |
|
43 |
2015/06/01 |
2036/01/17 |
28A-1040415 ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION |
|
28A-1040416 Drug molecules with targeting and effector moieties |
|||
|
28A-1040417 COMPOSITION AND METHOD FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASES OR AUTOIMMUNE DISEASES |
|||
|
28A-1040418 Transgenic animals capable of producing humanized IgE at much higher levels than mouse IgE |
|||
|
44 |
2022/05/25 |
2041/05/06 |
28A-1051024 Nasal spray universal influenza vaccine |
|
28A-1090304 A designer chimeric hemagglutinin elicits broad-protective CD4 and CD8 T-cell responses |
|||
|
45 |
2022/01/03 |
2039/11/17 |
28A-1061204 ESI MS for Micro-Sized Bioparticles |
|
28A-1020910 Automatic Amino Acid Sequencing of Glycopeptide by Y1 Ions |
|||
|
28A-1020201 Portable High Performance Liquid Chromatography |
|||
|
28A-1020201B HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH UV-VISIBLE DETECTION |
|||
|
28A-1000927 Periodic Field Differential Mobility Analyzer |
|||
|
28A-990722B Frequency Scan Linear Ion Trap Mass Spectrometry |
|||
|
28A-980911 Method of single ultra-large molecular ion detection |
|||
|
28A-971223 Biomolecule Accelerator |
|||
|
28A-971223B Molecular Ion Accelerator |
|||
|
28A-971223C Molecular Ion Accelerator |
|||
|
46 |
2021/08/03 |
2041/12/29 |
28T-1090204 Method for organoid generation |
|
28A-1090203 3D cell culture technology and its applications |
|||
|
47 |
2022/05/25 |
2042/04/11 |
28A-1100423 Monoglycosylated spike vaccine for SARS-CoV-2 and its variants of concern |
|
28A-1101026 Broad-spectrum SARS-CoV-2 mRNA vaccine |
|||
|
48 |
2022/05/25 |
2042/12/26 |
28A-1100723 A chimera monoclonal antibody possesses protective activity against various SARA-CoV-2 variants |
|
28A-1101116 Monoglycosylated Spike protein-elicited monoclonal antibodies in mice possess protective activity against various SARS-CoV-2 variants |
|||
|
28A-1080311 Synthesis of Sialidase-Resistant Oligosaccharide and Antibody Glycoform Containing α2,6-Linked 3Fax-Neu5Ac |
|||
|
49 |
2005/06/16 |
2025/06/15 |
28T-931014 Methods and compositions associated with administration of an extract of Ganoderma lucidium |
|
28A-970321 The effect of Reishi-derived polysaccharide and acetic acid on the lifespan of Caenorhabditis elegans |
|||
|
03A-900801 Fucose containing polypeptides and glycopeptides from Ganoderma ludicum |
|||
|
50 |
2009/05/30 |
2029/05/30 |
28A-940701 Fingerprints of polysaccharides by recombinant lectin receptor-Fc Fusion proteins |
|
28A-940701B Compositions and methods for identifying response targets and treating flavivrus infection responses |
|||
|
28A-940701D Compositions and methods for identifying response targets and treating flavivrus infection responses |
|||
|
51 |
2009/02/12 |
2029/03/26 |
28A-951222 Use of Alpha-galactosyl ceramide analogs as anti-cancer agents |
|
28A-951222B Alpha-galactosyl ceramide analogs and their use as immunotherapies |
|||
|
52 |
2007/09/18 |
2027/09/17 |
28A-960917 Identification of antibacterial and anti-influenza components from fermentation broth samples |
|
53 |
2010/07/26 |
2030/3/9 |
28A-970708 Globo H and related anti-cancer vaccines with novel glycolipid adjuvants |
|
28-970408 Cancer diagnosis based on levels of antibodies against Globo H and its fragments |
|||
|
54 |
2009/07/20 |
2043/08/31 |
28A-980327 Development of vaccines in the prevention of viral infection |
|
28A-980327B Methods For Producing Mono-Glycosylated Influenza Virus Hemagglutinin |
|||
|
28A-980327C Methods and Compositions for Immunization Against Virus |
|||
|
28A-980327D METHODS FOR PRODUCING VIRUS PARTICLES WITH SIMPLIFIED GLYCOSYLATION OF SURFACE PROTEINS |
|||
|
55 |
2013/04/12 |
2036/01/24 |
28A-960213 Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo |
|
28A-960214 Alkynyl sugar analogs for labeling and visualization of glycoconjugates in cells |
|||
|
28A-960215 Tailored Glycoproteomic Methods For The Sequencing, Mapping and Identification of Cellular Glycoproteins |
|||
|
28A-970407 Quantitative Microarray of Intact Glycolipid CD1d Interaction and Correlation with Cell-Based Cytokine Production |
|||
|
28A-970410 QUANTITATIVE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTIONS USING GLYCAN MICROARRAYS |
|||
|
28A-970411 Glycan arrays on PTFE-like aluminum coated glass slides and related methods |
|||
|
28A-980326 Alpha-Selective Sialyl Phosphate Donors For Preparation Of Sialosides And Sialoside Arrays For Influenza Virus |
|||
|
28A-981130 Methods for modifying human antibodies by glycan engineering |
|||
|
28A-990205 Glycan Arrays For High Throughput Screening Of Viruses |
|||
|
28A-990315 Synthesis of Zanamivir Phosphonate Congeners with Anti-influenza Activity |
|||
|
28A-1010120 Enhanced Anti-Influenza Agents Conjugated With Anti-Inflammatory Activity |
|||
|
28A-1010801 Cell-Permeable Probes For Identification And Imaging Of Sialidases |
|||
|
28A-1010815 BENZOCYCLOOCTYNE AND THEIR USES |
|||
|
28A-1020501 GLYCAN CONJUGATES AND USE THEREOF |
|||
|
28A-1020503 RM2 ANTIGENS AND USE THEREOF |
|||
|
28A-1020726 human iNKT cell activation using glycolipids with altered glycosyl groups |
|||
|
28A-1021222 COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS |
|||
|
28A-1030122 ANTI-CD20 GLYCOANTIBODIES AND USES THEREOF |
|||
|
28A-1030123 ANTI-CD20 GLYCOANTIBODIES AND USES THEREOF |
|||
|
28A-1030124 Anti-TNF-alpha Glycoantibodies and Uses Thereof |
|||
|
28A-1030207 FUCOSIDASE FROM BACTEROIDES AND METHODS USING THE SAME |
|||
|
28A-1030321 AZiDO-BODIPY COMPOUNDS AND USES THEREOF |
|||
|
28A-1030901 HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
|||
|
28A-1031208 NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF |
|||
|
28A-1040122 COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY |
|||
|
28A-1040122B COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY |
|||
|
28A-1041211 CANCER MARKERS AND METHODS OF USE THEREOF |
|||
|
28A-1050312 Methods for Modular Synthesis of N-glycans and Arrays Thereof |
|||
|
56 |
2011/04/01 |
2030/02/25 |
28A-990329 Anti-CemX antibodies capable of binding to human mIgE on B lymphocytes |
|
57 |
2019/06/01 |
2031/10/25 |
28A-990908 Computer-Modeled Novel Cancer Targeting Peptides for Therapy and Imaging |
|
58 |
2012/01/01 |
2112/01/01 |
32T-1010510 自動化音樂使用情境辨識 |
|
59 |
2012/01/01 |
2112/01/01 |
32T-1010511 人類動作影片相似度匹配 |
|
60 |
2023/8/15 |
2043/6/7 |
03A-1110221 Potent ionizable cationic lipids, methods for preparation and applications of use thereof |
|
10A-1040107 An Epitope-Substituted Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2 |
|||
|
10A-1111123 Safety and Immunogenicity of mRNA Vaccine against Dengue Virus Serotype2 |
|||
|
61 |
2021/5/18 |
2031/5/17 |
10A-1090507 MANUFACTURE METHOD OF FISH RNA INTERFERENCE REAGENT |
|
62 |
2023/9/1 |
2043/4/5 |
28A-1101015 Composition and application of anti-CD33（Siglec-3）mAbs for the treatment of chronic hepatitis B virus infrction |
|
63 |
2015/1/6 |
2026/1/5 |
21T-1031227 經典譯注計畫研究成果 |
|
64 |
2021/12/16 |
2299/12/31 |
25T-1100602 Property Law: Comparative, Economic, and Empirical Analyses |
|
65 |
2022/12/1 |
2032/11/30 |
13A-1070619 Display of spike protein from porcine epidemic diarrhea virus on baculovirus as a vaccine and thereof |
已專屬授權技術清單查詢
分享到：
